Conditions & Recovery · NY Times Health · August 26, 2026

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Explore the original story for the publisher’s full reporting.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Related learning